Article
NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors
medRxiv · 2024 · Hill, C.; Indeglia, A.; Picone, F.; Murphy, M.; Cipriano, C.; Maki, R. G.; Gardini, A.
Key facts
| Title | NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors |
|---|---|
| First author | Hill, C.; Indeglia, A.; Picone, F.; Murphy, M.; Cipriano, C.; Maki, R. G.; Gardini, A. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.04.15.589533 |
| Devices mentioned | K202641, K221932, K231013, K823719 |
| Product codes mentioned | HKI, KPS, QBD, JRR, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1